efficacy of PRP versus topical 5% minoxidil spray in treatmemt of pattern baldness

efficacy of platelet rich plasma versus5% topical minoxidil for the treatment of androgenetic alopecia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210811052139N1

Enrollment

Registered

2021-10-29

Start date

2021-11-01

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic Alopecia. Androgenic alopecia, unspecified

Interventions

Intervention 1: Intervention group 1: After all aseptic measures 30 ml of venous blood will be drawn into a tube containing citrate phosphate dextrose (prevent platelet activation and degranulation),

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18 to 60 years patient has not taken any kind of medical treatment for hair loss or has not used treatment for more than 6 months duration duration of AGA >6months Patient Hamilton-Norwood grade =2 and = 5 or Ludwig scale grade 1-2. Platelets count more than150, 000 /µl

Exclusion criteria

Exclusion criteria: ? Patients with alopecia other than AGA, such as telogen effluvium, alopecia areata, acquired cicatricial alopecia, or anagen effluvium. The patient on warfarin or heparin the infective disease of scalp patoents who has taken any treatment for AGA history of thyroid disorder patient with hypersensitivity to minoxidil in past any infective skin disease pregnancy/lactation patient takinh aspirin unrealistic expectation

Design outcomes

Primary

Measure	Time frame
Patient satisfaction score. Timepoint: 6 month. Method of measurement: this is measured by using standarize patient satisfaction score,0: no improvement 1: 1%–25% improvement 2: 25%–50% improvement 3: 50%–75% improvement 4: 76%–100% improvement.;Investigator 7 point score,. Timepoint: 0 and 6 month, - 3 = greatly decreased -2 = moderately decreased-1 = slightly decreased0 = no change 1 = slightly increased 2 = moderately increased3 = greatly increased. Method of measurement: using serial photograph taken at 0,3 and 6 months,improvement in hair density will be noted.;Patient standardized hair growth questionnaire. Timepoint: 6 month. Method of measurement: with answer of questions regarding hair loss.;Photographic evaluation. Timepoint: at 0, 3, and 6 months. Method of measurement: photographic evaluation,patient satisfaction score ,investigator 7 point score,Patient standardized hair growth questionnaire.	—

Measure

Time frame

Patient satisfaction score. Timepoint: 6 month. Method of measurement: this is measured by using standarize patient satisfaction score,0: no improvement 1: 1%–25% improvement 2: 25%–50% improvement 3: 50%–75% improvement 4: 76%–100% improvement.;Investigator 7 point score,. Timepoint: 0 and 6 month, - 3 = greatly decreased -2 = moderately decreased-1 = slightly decreased0 = no change 1 = slightly increased 2 = moderately increased3 = greatly increased. Method of measurement: using serial photograph taken at 0,3 and 6 months,improvement in hair density will be noted.;Patient standardized hair growth questionnaire. Timepoint: 6 month. Method of measurement: with answer of questions regarding hair loss.;Photographic evaluation. Timepoint: at 0, 3, and 6 months. Method of measurement: photographic evaluation,patient satisfaction score ,investigator 7 point score,Patient standardized hair growth questionnaire.

—

Countries

Pakistan

Contacts

Public ContactGhazal afzal

PNS shifa karachi

ghazalafzal@outlook.com+92 21 48506482

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026